References
Cummings SR, Martin JS, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756–765
Anastasilakis AD, Toulis KA, Goulis DG et al (2009) Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis. Horm Metab Res 41(10):721–729
Ellis GK, Bone HG, Chlebowski R et al (2008) Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol 20, 26(30):4875–4882
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s00198-010-1173-x
Rights and permissions
About this article
Cite this article
A. Toulis, K., D. Anastasilakis, A. Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab. Osteoporos Int 21, 1963–1964 (2010). https://doi.org/10.1007/s00198-009-1145-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-009-1145-1